Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 13, Issue 5

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 13, Issue 5 (2014)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 13, Issue 5 (2014)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Volume 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Do we need to worry about mycophenolate overdose?

Guido Filler & Amaryllis Ferrand

Pages: 521-524

Published online: 01 Apr 2014

AbstractforDo we need to worry about mycophenolate overdose? | Full Text | References | PDF (142.8 KB)

4789 Views
8 CrossRef citations
0Altmetric

Free Access

Original Research

Article

Acute mycophenolate overdose: case series and systematic literature analysis

Alessandro Ceschi, Claudia Gregoriano, Christine Rauber-Lüthy, Hugo Kupferschmidt, Nicholas R Banner, Stephan Krähenbühl & Anne B Taegtmeyer

Pages: 525-534

Published online: 21 Mar 2014

AbstractforAcute mycophenolate overdose: case series and systematic literature analysis | Full Text | References | PDF (200.5 KB) | Supplemental

406 Views
10 CrossRef citations
0Altmetric

Reviews

Review Article

Targeting the epidermal growth factor receptor in solid tumors: focus on safety

Eleonora Lucchini MD, Sara Pilotto MD, Elisa Spada MD, Davide Melisi MD PhD, Emilio Bria MD & Giampaolo Tortora MD PhD

Pages: 535-549

Published online: 01 Apr 2014

AbstractforTargeting the epidermal growth factor receptor in solid tumors: focus on safety | Full Text | References | PDF (291.6 KB)

384 Views
26 CrossRef citations
0Altmetric

Review Article

Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles

Francesco Locatelli MD FRCP, Lucia Del Vecchio MD, Leano Violo MD & Giuseppe Pontoriero MD

Pages: 551-561

Published online: 05 Apr 2014

AbstractforPhosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles | Full Text | References | PDF (263.4 KB)

803 Views
46 CrossRef citations
0Altmetric

Review Article

Glucocorticoid therapy for gastrointestinal diseases

George Triadafilopoulos MD

Pages: 563-572

Published online: 17 Apr 2014

AbstractforGlucocorticoid therapy for gastrointestinal diseases | Full Text | References | PDF (238.9 KB)

307 Views
5 CrossRef citations
0Altmetric

Review Article

Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies

Francesco Salvo MD PhD, Stefania Antoniazzi PharmD, Mai Duong PharmD, Mathieu Molimard MD PhD, Fabienne Bazin PhD, Annie Fourrier-Réglat PharmD PhD, Antoine Pariente MD PhD & Nicholas Moore MD PhD

Pages: 573-585

Published online: 03 Apr 2014

AbstractforCardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies | Full Text | References | PDF (284.5 KB)

929 Views
36 CrossRef citations
0Altmetric

Review Article

An evidence based systematic review of remifentanil associated opioid-induced hyperalgesia

Ryan M Rivosecchi PharmD, Mark J Rice, Pamela L Smithburger, Mitchell S Buckley, James C Coons & Sandra L Kane-Gill

Pages: 587-603

Published online: 26 Mar 2014

AbstractforAn evidence based systematic review of remifentanil associated opioid-induced hyperalgesia | Full Text | References | PDF (381.8 KB)

980 Views
38 CrossRef citations
0Altmetric

Review Article

Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review

Marc De Hert MD PhD, Johan Detraux & Joseph Peuskens MD PhD

Pages: 605-624

Published online: 03 Apr 2014

AbstractforSecond-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review | Full Text | References | PDF (382.2 KB)

927 Views
38 CrossRef citations
0Altmetric

Review Article

The safety of novel drugs used to treat irritable bowel syndrome

Shilan Mozaffari, Shekoufeh Nikfar & Mohammad Abdollahi

Pages: 625-638

Published online: 26 Mar 2014

AbstractforThe safety of novel drugs used to treat irritable bowel syndrome | Full Text | References | PDF (618.7 KB)

476 Views
14 CrossRef citations
0Altmetric

Drug Safety Evaluations

Article

Dabigatran etexilate for venous thromboembolism: a safety evaluation

Richard Brown MRCP, Gregory YH Lip MD & Pilar Gallego MD PhD

Pages: 639-647

Published online: 05 Mar 2014

Abstractfor Dabigatran etexilate for venous thromboembolism: a safety evaluation | Full Text | References | PDF (263.6 KB) | Supplemental

369 Views
2 CrossRef citations
0Altmetric

Article

Efficacy and safety of etanercept in chronic immune-mediated disease

Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Ottavia Magnani & Francesco Puppo

Pages: 649-661

Published online: 22 Mar 2014

AbstractforEfficacy and safety of etanercept in chronic immune-mediated disease | Full Text | References | PDF (304.1 KB)

780 Views
24 CrossRef citations
0Altmetric

Article

Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients

Olivier Huillard MD, Emilie Boissier, Benoit Blanchet, Audrey Thomas-Schoemann, Anatole Cessot, Pascaline Boudou-Rouquette, Jean-Philippe Durand, Romain Coriat, Julie Giroux, Jerome Alexandre, Michel Vidal & Francois Goldwasser

Pages: 663-673

Published online: 03 Apr 2014

AbstractforDrug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients | Full Text | References | PDF (321 KB)

355 Views
15 CrossRef citations
0Altmetric

Key Paper Evaluation

Article

Gliptins – do they increase cardiovascular risk or benefit?

Evaluation of Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Eng J Med 2013;369:1317-26 and White WB, Cannon CP, Heller SR, et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 2013;369:1327-35.

Sheila A Doggrell PhD DSc & Simon B Dimmitt MBBS FRACP FCSANZ

Pages: 675-680

Published online: 01 Apr 2014

AbstractforGliptins – do they increase cardiovascular risk or benefit? | Full Text | References | PDF (168.5 KB)

481 Views
17 CrossRef citations
0Altmetric

Research Article

Article

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

An update on the safety of lanreotide autogel for the treatment of patients with neuroendocrine tumors

Aayushi Sood et al.

Review Article | Published online: 7 Jun 2024

Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS)

Roger S. McIntyre et al.

Article | Published online: 3 Jun 2024

Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach

Desirèe Speranza et al.

Review Article | Published online: 3 Jun 2024

An overview of the efficacy and safety of β₂-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease

Maria Gabriella Matera et al.

Review Article | Published online: 2 Jun 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.13, Iss.5, 2014)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?